AJMC April 14, 2021

Brenden O’Hara, RPh, BCACP, is a clinical pharmacist in Provider Engagement Initiatives at Blue Cross Blue Shield of North Carolina.

Transcript:

How can pharmacists improve outcomes in value-based contracts, particularly in the use of specialty therapies?

O’Hara: Lots of different ways. So, what we do in working with our pharmacists is understanding what their day entails and what their work is already doing, and then help support them with data and information and additional views of some of the members that would have that direct desired outcome—direct potential cost of care and different quality improvement outcomes. We share that information with our partners.

Specialty is definitely a big focus. We’re not having many of our chronic disease state medications coming...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Payment Models, Pharma, Pharma / Biotech, Provider, Trends, Value Based
Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform
Physician-led ACOs are the most effective at reducing care costs: report
CVS, inVio creating South Carolina ACO through REACH
‘Capital Will Follow Where There’s Predictability’: Ideal Option CEO Connects Value-Based Care and Enterprise Value
Value-based care adoption is a journey, not a destination. And the map you follow can make all the difference

Share This Article